Supplementary Methods S5 from Safety and Preliminary Efficacy of Pembrolizumab Following Transarterial Chemoembolization for Hepatocellular Carcinoma: The PETAL Phase Ib Study | Synapse
June 3, 2024Open Access
Supplementary Methods S5 from Safety and Preliminary Efficacy of Pembrolizumab Following Transarterial Chemoembolization for Hepatocellular Carcinoma: The PETAL Phase Ib Study
Key Points
Key points are not available for this paper at this time.
Abstract
Supplementary Methods 5. Complete list of the targeted genes profiled using the NanoString PanCancer Immune panel.